Jingde Chen

543 total citations
21 papers, 370 citations indexed

About

Jingde Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jingde Chen has authored 21 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jingde Chen's work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Jingde Chen is often cited by papers focused on RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Jingde Chen collaborates with scholars based in China and United States. Jingde Chen's co-authors include Yong Gao, Jiujie Cui, Ming Quan, Liwei Wang, Jiao Feng, Haiyan Yang, Yandong Li, Zhuqing Zhou, Shijun Yu and Ning Li and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Jingde Chen

21 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingde Chen China 10 279 128 90 78 44 21 370
Baocun Sun China 8 298 1.1× 231 1.8× 100 1.1× 44 0.6× 34 0.8× 9 399
Véronique Barrès Canada 10 212 0.8× 82 0.6× 99 1.1× 59 0.8× 46 1.0× 19 373
Suzana Gomes United States 8 326 1.2× 103 0.8× 103 1.1× 36 0.5× 31 0.7× 14 448
Arin Nam United States 11 274 1.0× 119 0.9× 150 1.7× 115 1.5× 42 1.0× 22 443
Yvonne E. Smith Ireland 9 228 0.8× 130 1.0× 185 2.1× 140 1.8× 32 0.7× 10 430
Nahyeon Kang South Korea 7 260 0.9× 204 1.6× 167 1.9× 83 1.1× 23 0.5× 17 419
Marion Gilormini France 5 169 0.6× 93 0.7× 138 1.5× 83 1.1× 30 0.7× 7 329
Nanhang Lu China 7 263 0.9× 151 1.2× 86 1.0× 48 0.6× 30 0.7× 16 357
Robiya Joseph United States 8 244 0.9× 134 1.0× 133 1.5× 67 0.9× 19 0.4× 18 362
Wenzheng Yuan China 8 304 1.1× 176 1.4× 179 2.0× 64 0.8× 31 0.7× 8 458

Countries citing papers authored by Jingde Chen

Since Specialization
Citations

This map shows the geographic impact of Jingde Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingde Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingde Chen more than expected).

Fields of papers citing papers by Jingde Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingde Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingde Chen. The network helps show where Jingde Chen may publish in the future.

Co-authorship network of co-authors of Jingde Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jingde Chen. A scholar is included among the top collaborators of Jingde Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingde Chen. Jingde Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Shijun, et al.. (2024). WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma. Cancer Research. 84(17). 2776–2791. 6 indexed citations
2.
Hu, Qingqing, et al.. (2024). JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development. Journal of Cell Communication and Signaling. 18(1). e12017–e12017. 1 indexed citations
3.
4.
Wang, Jialin, et al.. (2023). PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma. Pharmacological Research. 196. 106915–106915. 16 indexed citations
5.
Chen, Jingde, et al.. (2022). TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer. Pharmaceutical Research. 40(3). 689–699. 3 indexed citations
6.
Zhu, Zhe, et al.. (2022). Transcriptome Profiling Analysis Identifies LCP1 as a Contributor for Chidamide Resistance in Gastric Cancer. Pharmaceutical Research. 39(5). 867–876. 6 indexed citations
7.
Chen, Jingde, Ming Quan, Zhengqing Yan, et al.. (2021). Distribution of BRCA1/2 germline and somatic alterations across cancer type.. Journal of Clinical Oncology. 39(15_suppl). 10590–10590. 1 indexed citations
8.
Quan, Ming, Jiao Feng, Xiuying Xiao, et al.. (2020). Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression. Journal of Experimental & Clinical Cancer Research. 39(1). 13–13. 19 indexed citations
9.
Chen, Jingde, Ming Quan, Zhiqin Chen, et al.. (2020). Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial. Journal of Cancer Research and Clinical Oncology. 146(10). 2651–2657. 11 indexed citations
10.
Yang, Haiyan, Jiong Hu, Jingde Chen, et al.. (2020). RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer. Medical Oncology. 37(9). 84–84. 8 indexed citations
11.
Li, Yandong, Shijun Yu, Li Li, et al.. (2020). KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell Death and Disease. 11(4). 299–299. 36 indexed citations
12.
Chen, Jingde, Bei Zhang, Yifan Zhou, Xiaochen Zhao, & Yuezong Bai. (2020). Resting memory CD4+ T cells and plasma cells in gastric cancer may be potential immune biomarkers.. Journal of Clinical Oncology. 38(15_suppl). e16523–e16523. 2 indexed citations
13.
Cui, Jiujie, Zhuqing Zhou, Haiyan Yang, et al.. (2019). MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Molecular Cancer Research. 17(6). 1316–1325. 101 indexed citations
14.
Chen, Jingde, Lin Chen, Jing Wu, et al.. (2019). High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications. Journal of Nanobiotechnology. 17(1). 116–116. 24 indexed citations
15.
Cui, Jiujie, Ming Quan, Dacheng Xie, et al.. (2019). A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism. Oncogene. 39(5). 1140–1151. 45 indexed citations
16.
Chen, Jingde, et al.. (2018). FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling. Experimental Cell Research. 374(1). 12–18. 10 indexed citations
17.
Wu, Qiong, Shijun Yu, Jingde Chen, Yandong Li, & Yong Gao. (2017). Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level. IUBMB Life. 70(2). 120–128. 7 indexed citations
18.
Chen, Jingde, et al.. (2017). Targeting long non-coding RNA HERC2P3 inhibits cell growth and migration in human gastric cancer cells.. PubMed. 10(7). 7632–7639. 4 indexed citations
19.
Li, Qi, Hui‐Chun Wang, Jun Zhou, et al.. (2014). ChIP-seq predicted estrogen receptor biding sites in human breast cancer cell line MCF7. Tumor Biology. 35(5). 4779–4784. 4 indexed citations
20.
Jiang, Hong, Xuemei Zhang, J. L. Luo, et al.. (2012). Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells. Molecular Medicine Reports. 6(3). 575–580. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026